CINDY CRUZ: Open Payments
NPI 1982910709 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,154 in 90 payments from 15 companies in 2025. Trend: 2023 $1,170 · 2024 $2,403 · 2025 $3,154
Food & beverage: $3,154
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 19 | $603 |
| Novo Nordisk Inc | 14 | $468 |
| Axsome Therapeutics, Inc. | 10 | $456 |
| ABBVIE INC. | 14 | $397 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $392 |
| AstraZeneca Pharmaceuticals LP | 5 | $215 |
| Merck Sharp & Dohme LLC | 2 | $146 |
| Phathom Pharmaceuticals, Inc. | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| SI-BONE, INC. | 1 | $92 |
Products named: Auvelity, Kerendia, VRAYLAR, JARDIANCE, Ozempic, BREZTRI, MOUNJARO, Rybelsus.
Industry payments across TX — which companies pay providers there.
